Gleissner, Beate <br/><br/>
Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia--ongoing trials.  [electronic resource] 

 -  Onkologie  Dec 2007 
 - 657-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1423-0240 
<br/><br/><label>Standard No.: </label>10.1159/000109956  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminoglycosides--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--administration & dosage<br/>Clinical Trials as Topic--trends<br/>Gemtuzumab<br/>Germany<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Practice Patterns, Physicians'--trends<br/>Treatment Outcome